XML 24 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Non-marketable Securities
3 Months Ended
Mar. 31, 2024
Non-marketable Securities  
Non-marketable Securities

Note 4 Non-marketable Securities

The carrying balance of non-marketable securities are summarized as follows as of the dates indicated:

March 31, 2024

December 31, 2023

Federal Reserve Bank stock

$

24,062

$

24,062

Federal Home Loan Bank stock

779

16,828

Convertible preferred stock

24,415

25,000

Equity method investments

24,183

24,587

Total

$

73,439

$

90,477

Non-marketable securities included FRB stock, FHLB stock and other non-marketable securities. During the three months ended March 31, 2024, purchases of non-marketable securities totaled $10.3 million, and proceeds from non-marketable securities totaled $27.1 million. Purchases consisted primarily of FHLB stock, and proceeds consisted of redemptions of FHLB stock. Changes in the Company’s FHLB stock holdings were directly correlated to FHLB line of credit advances and paydowns. During the three months ended March 31, 2023, purchases of non-marketable securities totaled $35.9 million, and proceeds from non-marketable securities totaled $4.7 million.

FRB and FHLB stock

At March 31, 2024 and December 31, 2023, the Company held FRB stock and FHLB stock for regulatory or debt facility purposes. These are restricted securities which, lacking a market, are carried at cost. There have been no identified events or changes in circumstances that may have an adverse effect on the FRB and FHLB stock carried at cost.

Other non-marketable securities

Other non-marketable securities consist of equity method investments and convertible preferred stock without a readily determinable fair value. During the three months ended March 31, 2024 and 2023, the Company recorded net unrealized losses on equity method investments totaling $49.7 thousand and net unrealized gains on equity method investments totaling $0.2 million, respectively. These gains and losses were recorded in other non-interest income in the Company’s consolidated statements of operations. No impairments were recorded during the three months ended March 31, 2024 or 2023.